0 — Class II drug recall D-183-2013
Terminated recall by Hospira Inc., reported 2013-03-13, distributed nationwide. Lack of Assurance of Sterility: There is the potential for solution to leak from the administrative port to th
| Recall number | D-183-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2013-01-08 |
| Classified | 2013-03-07 |
| Reported by FDA | 2013-03-13 |
| Terminated | 2015-05-15 |
| Distributed | Nationwide (US) |
| Quantity | 325,056 bags |
| Reason classes | sterility, packaging |
| NDC | 00409-7984-23 |
| Lot numbers | 02-117-JT, 02/13 |
Product
0.9% Sodium Chloride Injection USP, 100 mL Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7984-23,
Reason for recall
Lack of Assurance of Sterility: There is the potential for solution to leak from the administrative port to the fill tube seal.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-183-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.